BIORESTORATIVE THERAPIES, INC. Lease, Cost
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Lease, Cost of $174.35 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-26
- BIORESTORATIVE THERAPIES, INC. lease, cost for the quarter ending 2024-12-31 was $43.27K, a 2.99% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. lease, cost for the quarter ending 2024-09-30 was $43.27K, a 2.99% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. lease, cost for the quarter ending 2024-06-30 was $43.27K, a 2.99% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. lease, cost for the quarter ending 2024-03-31 was $43.27K, a 2.99% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. lease, cost for fiscal 2025 was $174.35K, a 0.75% increase from fiscal 2024.
- BIORESTORATIVE THERAPIES, INC. lease, cost for fiscal 2024 was $173.06K, a 2.99% increase from fiscal 2023.
- BIORESTORATIVE THERAPIES, INC. lease, cost for fiscal 2023 was $168.03K, a 3.00% increase from fiscal 2022.
- BIORESTORATIVE THERAPIES, INC. lease, cost for fiscal 2022 was $163.13K, a 3.01% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $174.35K 10-K · filed 2026-03-26 | |||
| 2024-12-31 | $43.27K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $86.53K derived: sum of 2 quarters · filed 2026-03-26 | $129.79K derived: sum of 3 quarters · filed 2026-03-26 | $173.06K 10-K · filed 2026-03-26 |
| 2024-09-30 | $43.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $86.53K derived: sum of 2 quarters · filed 2024-11-12 | $129.79K 10-Q · filed 2024-11-12 | $171.80K derived: sum of 4 quarters · filed 2025-03-28 |
| 2024-06-30 | $43.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $86.53K 10-Q · filed 2024-08-13 | $128.54K derived: sum of 3 quarters · filed 2025-03-28 | $170.54K derived: sum of 4 quarters · filed 2025-03-28 |
| 2024-03-31 | $43.27K 10-Q · filed 2024-06-11 | $85.27K derived: sum of 2 quarters · filed 2025-03-28 | $127.28K derived: sum of 3 quarters · filed 2025-03-28 | $169.29K derived: sum of 4 quarters · filed 2025-03-28 |
| 2023-12-31 | $42.01K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $84.01K derived: sum of 2 quarters · filed 2025-03-28 | $126.02K derived: sum of 3 quarters · filed 2025-03-28 | $168.03K 10-K · filed 2025-03-28 |
| 2023-09-30 | $42.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $84.01K derived: sum of 2 quarters · filed 2024-11-12 | $126.02K 10-Q · filed 2024-11-12 | $166.80K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $42.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $84.01K 10-Q · filed 2024-08-13 | $124.80K derived: sum of 3 quarters · filed 2024-08-13 | $165.58K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $42.01K 10-Q · filed 2024-06-11 | $82.79K derived: sum of 2 quarters · filed 2024-06-11 | $123.57K derived: sum of 3 quarters · filed 2024-06-11 | $164.36K derived: sum of 4 quarters · filed 2024-06-11 |
| 2022-12-31 | $40.78K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-11 | $81.57K derived: sum of 2 quarters · filed 2024-06-11 | $122.35K derived: sum of 3 quarters · filed 2024-06-11 | $163.13K 10-K/A · filed 2024-06-11 |
| 2022-09-30 | $40.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $81.57K derived: sum of 2 quarters · filed 2023-11-13 | $122.35K 10-Q · filed 2023-11-13 | $161.94K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $40.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $81.57K 10-Q · filed 2023-08-11 | $121.16K derived: sum of 3 quarters · filed 2023-08-11 | $160.75K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $40.78K 10-Q · filed 2023-05-12 | $80.38K derived: sum of 2 quarters · filed 2023-05-12 | $119.97K derived: sum of 3 quarters · filed 2023-05-12 | $159.56K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $39.59K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $79.19K derived: sum of 2 quarters · filed 2023-03-27 | $118.78K derived: sum of 3 quarters · filed 2023-03-27 | $158.37K 10-K · filed 2023-03-27 |
| 2021-09-30 | $39.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $79.19K derived: sum of 2 quarters · filed 2022-11-14 | $118.78K 10-Q · filed 2022-11-14 | $157.22K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $39.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $79.19K 10-Q · filed 2022-08-15 | $117.62K derived: sum of 3 quarters · filed 2022-08-15 | $156.06K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $39.59K 10-Q · filed 2022-05-16 | $78.03K derived: sum of 2 quarters · filed 2022-05-16 | $116.47K derived: sum of 3 quarters · filed 2022-05-16 | $154.90K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $38.44K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $76.87K derived: sum of 2 quarters · filed 2022-03-30 | $115.31K derived: sum of 3 quarters · filed 2022-03-30 | $153.75K 10-K · filed 2022-03-30 |
| 2020-09-30 | $38.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $76.87K derived: sum of 2 quarters · filed 2021-11-15 | $115.31K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $38.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $76.87K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $38.44K 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $62.19K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |